ChemBioChem · 2016 · 28 citations · 26 references
PharmacyMedicinal ChemistryMolecular BiologyAntimicrobial ResistanceDrug DiscoveryProdrug DesignAntibacterial AgentsAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceEnzyme InhibitionProdrug Activation MechanismsAntibiotic DiscoveryAntibiotic Mechanisms Of ActionCarbohydrate-derived AntibioticsGlycopeptide AntibioticsNovel Antibacterial Drug DiscoveryProdrug SelectivityRibozyme-mediated CleavageRibozymes
The ever-growing number of pathogenic bacteria resistant to treatment with antibiotics call for the development of novel compounds with as-yet unexplored modes of action. Here, we demonstrate the in vivo antibacterial activity of carba-α-d-glucosamine (CGlcN). In this mode of action study, we provide evidence that CGlcN-mediated growth inhibition is due to glmS ribozyme activation, and we demonstrate that CGlcN hijacks an endogenous activation pathway, hence utilizing a prodrug mechanism. This is the first report describing antibacterial activity mediated by activating the self-cleaving properties of a ribozyme. Our results open the path towards a compound class with an entirely novel and distinct molecular mechanism.
26
Essential <i>Bacillus</i> <i>subtilis</i> genes
Kazuo Kobayashi, S. Dusko Ehrlich, Alberto Albertini et al. · Proceedings of the National Academy of Sciences · 2003 · 1.3K citations · Full text
Control of gene expression by a natural metabolite-responsive ribozyme
Wade C. Winkler, Ali Nahvi, Adam Roth et al. · Nature · 2004 · 954 citations
Selective small-molecule inhibition of an RNA structural element
John A. Howe, Hao Wang, Thierry Fischmann et al. · Nature · 2015 · 417 citations
Term-seq reveals abundant ribo-regulation of antibiotics resistance in bacteria
Daniel Dar, Maya Shamir, J. R. Mellin et al. · Science · 2016 · 381 citations · Full text